Naoko Takebe to Neurofibromin 2
This is a "connection" page, showing publications Naoko Takebe has written about Neurofibromin 2.
Connection Strength
0.247
-
Phase II Study of Defactinib (VS6063) in Patients With Tumors With NF2 Loss: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol U. JCO Precis Oncol. 2024 Dec; 8:e2400327.
Score: 0.247